John A. Barrett

Discovery, Radiopharmaceutical Division, The DuPont Merck Pharmaceutical Company, 331 Treble Cove Road, N. Billerica, MA 01862, USA

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers71 papers

Sort

By YearBy Citation

One Year Follow-Up for the Phase I MTD Study of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma (Pheo):

R. Edward Coleman,Stanley J. Goldsmith,Richard B. Noto,Kimberly R. Pearson,Katherine A. Kacena,John A. Barrett,Norman D. LaFrance,John W. Babich

Pancreas, no. 2 (2010)

Bibtex

Comparison of High-Specific-Activity Ultratrace^123/131I-MIBG and Carrier-Added^123/131I-MIBG on Efficacy, Pharmacokinetics, and Tissue Distribution

John A. Barrett,John L. Joyal,Shawn M. Hillier,Kevin P. Maresca,Frank J. Femia,James F. Kronauge,Marie Boyd,Robert J. Mairs,John W. Babich

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, no. 3 (2010): 299-308

Bibtex

Small molecule PSMA inhibitors for targeted molecular imaging of prostate cancer

Shawn Hillier,Kevin P Maresca,Frank J Femia, Craig Zimmerman,John A Barrett,Catherine A Foss,William C Eckelman,Martin G Pomper,John Joyal,John W Babich

(2008)

Bibtex

Synthesis and evaluation of a series of M(CO)3+ [M=Tc,Re] lisinopril complexes for imaging angiotensin converting enzyme (ACE)

Frank J Femia,Kevin P Maresca, Shawn Hillier, Craig Zimmerman, John Joyal,John A Barrett, Thomas G Coleman,Omer Aras,Catherine A Foss,Martin G Pomper,Vasken Dilsizian,William C Eckelman

(2007)

Bibtex

⁹⁰Y and¹¹¹In Complexes of a DOTA-Conjugated Integrin α_vβ₃Receptor Antagonist: Different but Biologically Equivalent

David C. Onthank,Shuang Liu,Paula J. Silva,John A. Barrett,Thomas D. Harris,Simon P. Robinson,D. Scott Edwards

BIOCONJUGATE CHEMISTRY, no. 2 (2004): 235-241

Cited by4Bibtex

In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent

René M Botnar,Alexandra S Perez,Sonia Witte,Andrea J Wiethoff,James Laredo,James Hamilton,William Quist,Edward C Parsons,Anand Vaidya,Andrew Kolodziej,John A Barrett,Philip B Graham

Circulation, no. 16 (2004): 2023-2029

Cited by305WOSBibtex

STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF

Shuang Liu,John A Barrett, Alan P Carpenter

(2003)

Cited by8Bibtex

Pharmaceuticals for the imaging of angiogenic disorders

Milind Rajopadhye,D Scott Edwards,John A Barrett, Alan P Carpenter,Thomas D Harris, Stuart D Heminway,Shuang Liu, Singh R Prahlad

(2003)

Cited by38Bibtex

RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION

John A Barrett, Edward H Cheesman,Thomas D Harris,Shuang Liu,Milind Rajopadhye,Michael Sworin

(2003)

Cited by24Bibtex

Imaging thrombus with glycoprotein llb/llla antagonists

Milind Rajopadhye,John A Barrett

(2003)

Cited by6Bibtex

Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation

Peiman Hematti,Elaine M Sloand,Cristian A Carvallo,Michael R Albert,Carole L Yee,Monika M Fuehrer,Jan K Blancato,William G Kearns,John A Barrett,Richard W Childs,Jonathan C Vogel,Cynthia E Dunbar

Experimental Hematology, no. 8 (2002): 943-949

Cited by34WOSEIBibtex

Matrix metalloproteinase inhibitors and uses thereof

Carl P Decicco, D J Nelson,John A Barrett, Alan P Carpenter, James J Duran,Milind Rajopadhye

(2001)

Cited by2Bibtex

A rapid PCR based method to establish the potential for paternal inheritance of chloroplasts in Pelargonium

Celia M. James,John A. Barrett,Stephen J. Russell,Mary Gibby

Bibtex

A rapid PCR based method to establish the potential for paternal inheritance of chloroplasts inPelargonium

Celia M. James,John A. Barrett,Stephen J. Russell,Mary Gibby

Plant Molecular Biology Reporter, no. 2 (2001): 163-167

Cited by11Bibtex

^99mTc-Labeling of a Hydrazinonicotinamide-Conjugated Vitronectin Receptor Antagonist Useful for Imaging Tumors

Shuang Liu,D. Scott Edwards,Marisa C. Ziegler,Anthony R. Harris,Stuart J. Hemingway,John A. Barrett

BIOCONJUGATE CHEMISTRY, no. 4 (2001): 624-629

Cited by5Bibtex

Vitronectin receptor antagonist pharmaceuticals for use in combination therapy

John A Barrett, Alan P Carpenter, Edward H Cheesman,Thomas D Harris,Milind Rajopadhye

(2001)

Cited by12Bibtex

Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features

Y Saunthararajah,J L Molldrem,M Rivera,A Williams,M Stetler-Stevenson,L Sorbara,N S Young,J A Barrett

BRITISH JOURNAL OF HAEMATOLOGY, no. 1.0 (2001): 195-200

Cited by92WOSBibtex

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

J P Maciejewski,D Follmann,R Nakamura,Y Saunthararajah,C E Rivera,T Simonis,K E Brown,J A Barrett,N S Young

Blood, no. 13 (2001): 3513-3519

Cited by175WOSBibtex

Isozyme evidence for the origin of Potamogeton × sudermanicus as a hybrid between P. acutifolius and P. berchtoldii

Jeremie B. Fant,Chris D. Preston,John A. Barrett

Aquatic Botany, no. 3 (2001): 199-208

Cited by28EIBibtex

Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444

Wim J. G. Oyen,Otto C. Boerman,Frederieke M. Brouwers,John A. Barrett,Freek W. A. Verheugt,Dirk J. Ruiter,Frans H. M. Corstens,Jos W.M. van der Meer

European Journal of Nuclear Medicine and Molecular Imaging, no. 4 (2000): 392-399

Cited by26WOSBibtex

View All

Base Info Papers Patents Projects